SNDX-5613
SNDX-5613 Basic information
- Product Name:
- SNDX-5613
- Synonyms:
-
- SNDX-5613
- acute,Leukemia,inhibit,lymphoblastic,Epigenetic Reader Domain,Inhibitor,AML,Menin,ALL,SNDX 5613,SNDX-5613,SNDX5613,MLL,myeloid
- Benzamide, N-ethyl-2-[[4-[7-[[trans-4-[(ethylsulfonyl)amino]cyclohexyl]methyl]-2,7-diazaspiro[3.5]non-2-yl]-5-pyrimidinyl]oxy]-5-fluoro-N-(1-methylethyl)-
- SNDX-5613 SNDX5613
- Revumenib
- CAS:
- 2169919-21-3
- MF:
- C32H47FN6O4S
- MW:
- 630.82
- Mol File:
- 2169919-21-3.mol
More
Less
SNDX-5613 Chemical Properties
- Boiling point:
- 739.1±70.0 °C(Predicted)
- Density
- 1.28±0.1 g/cm3(Predicted)
- solubility
- DMSO:30.0(Max Conc. mg/mL);47.56(Max Conc. mM)
- pka
- 11.10±0.40(Predicted)
SNDX-5613Supplier
Shanghai SuperLan Chemcial Technique Centre Gold
- Tel
- 021-2022843681 15618226720
- chaolaichem@foxmail.com
SINO High Goal Chemical Technology Co., Ltd.
- Tel
- 021-57646680 18306277365
- sunkai@chembiobanksh.com
ShangHai Caerulum Pharma Discovery Co., Ltd.
- Tel
- 18149758185
- sales-cpd@caerulumpharma.com
Sichuan Wei Keqi Biological Technology Co., Ltd.
- Tel
- 028-81700200 18116577057
- 3003855609@qq.com
Shanghai Lollane Biological Technology Co.,Ltd.
- Tel
- 021-52996696，15000506266 15000506266
More
Less
SNDX-5613(2169919-21-3)Related Product Information
- SNS-062
- PF-04929113
- 4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((1r,4r)-4-hydroxycyclohexylamino)benzamide
- N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide hydrochloride
- N-(3-Chlorophenyl)-N'-[5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-2-thiazolyl]urea